Patent classifications
A23V2200/324
Additive for Detoxification
The present invention patent application relates essentially to an additive, the function of which is to enhance immunity, prevent various diseases and increase detoxification of the organism. The additive is composed of: 60 mcg of vitamin A; 4.5 mg of vitamin C; 1 mg of vitamin E; 3.4 mcg of selenium; 0.5 mg of copper; 0.7 mg of zinc; 0.23 mg of manganese; 3 mg of coenzyme Q10; 5 mg of pycnogenol; 0.13 mg of vitamin B2; 1.6 mg of vitamin B3; 0.13 mg of vitamin B6; 24 mcg of folic acid; 0.24 mcg of vitamin B12; 2 mg of glutathione; 100 mg of leucine; 20 mg of isoleucine; 20 mg of valine; 50 mg of glycine; 50 mg of taurine; 300 mg of glutamine; 60 mg of acetylcysteine; 50 mg of cysteine; 100 mg of methionine; 0.5 mg of vitamin B5; 2 mg of lycopene; and 4 mg of resveratrol.
METHOD OF TREATING OR PREVENTING AN INFECTION
Provided are compositions comprising at least one organism of a strain of the order Clostridiales and methods of use thereof for protecting against an infection, such as a viral, protozoal or fungal infection in an animal. Also provided are methods for improving hatchability of an egg under contaminated conditions by protecting against infection of an avian in ovo.
A composition for boosting the immune system
There is provided herein a composition for boosting the immune system comprising a keratin compound and beta-lactoglobulin (LGB).
A composition for boosting the immune system
There is provided herein a composition for boosting the immune system comprising a keratin compound and beta-lactoglobulin (LGB).
IMMUNOMODULATORY OLIGOSACCHARIDES
The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
IMMUNOMODULATORY OLIGOSACCHARIDES
The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR CORONAVIRUS INFECTION COMPRISING TETRAARSENIC HEXOXIDE
Disclosed herein is a pharmaceutical composition comprising tetraarsenic hexoxide as an active ingredient. Having excellent antiviral activity against coronaviruses, the pharmaceutical composition can be advantageously applied to the prevention or treatment of coronavirus diseases.
NOVEL LACTIC ACID BACTERIA HAVING EXCELLENT IMMUNE FUNCTION ENHANCEMENT EFFECT, AND FOOD COMPOSITION, HEALTH FUNCTIONAL FOOD COMPOSITION AND PROBIOTICS COMPRISING SAME
A novel Lactococcus lactis GCWB1176 strain deposited under Accession No. KCCM12687P and uses thereof are disclosed. The Lactococcus lactis GCWB1176 strain has an excellent immune function enhancing effect. In addition, a food composition, a health functional food composition and probiotics having an excellent immune function enhancing effect, containing the novel strain are disclosed.
REDEFINING LIVESTOCK MILK BY REMOVING FOLATE RECEPTOR PROTEIN TO DECREASE FOLATE RECEPTOR AUTOIMMUNE DISORDER IN PREGNANCY AND AUTISM
Provided herein are systems and methods in Redefining Cow Milk to decrease the prevalence of folate receptor autoimmune disorder in the population to reduce the Incidence of neural tube defect pregnancy, pre-term birth, subfertility and a plethora of developmental disorders including autism spectrum disorders.
REDEFINING LIVESTOCK MILK BY REMOVING FOLATE RECEPTOR PROTEIN TO DECREASE FOLATE RECEPTOR AUTOIMMUNE DISORDER IN PREGNANCY AND AUTISM
Provided herein are systems and methods in Redefining Cow Milk to decrease the prevalence of folate receptor autoimmune disorder in the population to reduce the Incidence of neural tube defect pregnancy, pre-term birth, subfertility and a plethora of developmental disorders including autism spectrum disorders.